Resolution of the consensus of the Russian Federation experts on the diagnosis and treatment of osteoarthritis, 2022

Author:

Lila A. M.1ORCID,Mazurov V. I.2ORCID,Martynov A. I.3ORCID,Zagorodny N. V.4ORCID,Alekseeva L. I.1ORCID,Chichasova N. V.1ORCID,Karateev A. E.5ORCID,Naumov A. V.6ORCID,Zonova E. V.7ORCID,Rachin A. P.8ORCID,Taskina E. A.5ORCID

Affiliation:

1. V.A. Nasonova Research Institute of Rheumatology; Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia

2. North-Western State Medical University named after I.I. Mechnikov, Ministry of Health of Russia

3. A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia

4. N.N. Priorov National Research Medical Center for Traumatology and Orthopedics, Ministry of Health of Russia

5. V.A. Nasonova Research Institute of Rheumatology

6. Pirogov Russian National Research Medical University, Ministry of Health of Russia

7. Novosibirsk State Medical University, Ministry of Health of Russia

8. National Medical Research Center for Rehabilitation and Balneology, Ministry of Health of Russia

Abstract

Osteoarthritis (OA) is the most common joint disease due to the increasing life expectancy of the world's population. Every 2nd patient over the age of 50 suffers from knee or hip OA, and this is directly related to the increased burden on healthcare. Accumulated data on the comorbid profile of patients with OA dictate the need to identify disease phenotypes in order to provide personalized care. Individual clinical manifestations of OA also require a differential approach: the pain treatment requires consideration of the patient's psycho-emotional profile and the possibility of involving nociceptive pathways in the process. However, due to the ambiguity of existing clinical guidelines, most experts note a number of difficulties in prescribing treatment for patients with OA.The resolution presents an agreed opinion of experts on the algorithms for managing patients with OA, starting from the primary level, with the gradual involvement of related specialists. Some issues of a personalized approach are considered depending on the presence of comorbid pathology and the severity of individual symptoms of the disease. The prospects of the combined use of pharmacological and non-drug methods of treatment are noted; emphasis was placed on the importance of rehabilitation measures at the first level of medical care, provided to patients with OA, long before the development of structural changes.The proposed algorithms for managing patients can be considered as the basis for future recommendations for managing patients with this pathology.

Publisher

IMA Press, LLC

Subject

Pharmacology (medical),Immunology,Immunology and Allergy,Rheumatology

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3